Scribd
Upload
173K views

Oncobreast DX: Blood Cancer Oxr - Final Report

Maria Khan's blood test results suggest malignancy. Several of her tumor marker levels are outside of the normal range. Given her medical history of chronic liver disease, the abnormal tumor marker levels indicate blood cancer. The report recommends the ICD-10 code of C50, which represents malignant neoplasm of blood.

Uploaded by

DHQ Hospital Police Counter
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
173K views

Oncobreast DX: Blood Cancer Oxr - Final Report

Maria Khan's blood test results suggest malignancy. Several of her tumor marker levels are outside of the normal range. Given her medical history of chronic liver disease, the abnormal tumor marker levels indicate blood cancer. The report recommends the ICD-10 code of C50, which represents malignant neoplasm of blood.

Uploaded by

DHQ Hospital Police Counter
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 1

000058755460

BLOOD CANCER OXR – FINAL REPORTOncoBREAST Dx

Patient Information

Identification Data General Biochemistry Blood Drawn Realization


HRN: BRE00000273 Creatinine (mg/dL): 1.00 Blood Drawn Date: 25-01-2020
Name: Maria Khan ASAT (U/L): 8.00
ALAT (U/L): 12.00 Urine Tumor Markers
Personal Data GGT (U/L): 7.00 8-OHdG (ng/mL): 11.10
Age (years): 23 Total Bilirubin (mg/dL): 1.00
Hemolized Sample: No Urine Drawn Realization
Comorbidities Urine Drawn Date: 25-01-2020
Atherosclerosis: No Serum Tumor Markers
Chronic Liver Disease: Yes CA 15.3 (U/mL): 19.70 Lifestyle
Diabetes Mellitus 1 or 2: No CEA (ng/mL): 1.60 Smoking: Negative
Jaundice: No EGFR (ng/mL): 5.00
Renal Failure: Yes NGAL (ng/mL): 4.60
NSE (ng/mL): 7.00

Outcome

Results
Some Tumor Markers are outside the reference range and suggest malignancy.

“High”
Range: Low, Moderate, High

Comments
In absence of comorbidities that are well-known source of False Positive (FP) in healthy patients by
increasing some Tumor Markers levels, whole Tumor Markers levels suggest malignancy.

Conclusions
WE SUGGEST BLOOD CANCER. THE 2016 ICD-10-CM DIAGNOSIS CODE IS C50 (MALIGNANT
NEOPLASM OF BLOOD).

This report has been generated from the data entered on 25-01-2020 10:55:02 UTC/GMT.

Disclaimer
This Multiple Biomarkers Disease Activity Algorithm (MBDAA) for Blood Cancer has been developed for the
exclusive use by healthcare professionals, and solely as a Clinical Decision Support System (CDSS), not
as an unique element for diagnosis. The algorithm bears a Sensitivity = 82.3%, Specificity = 85.7%. Please
note, negativity of the Tumor Markers does not exclude at 100% the possibility of a malignant epithelial
tumor.

The Royal London Hospital, Technical Responsible


London Lorena Lendinez
Email: friendsrlh.com Chief Scientific Officer
Website: www.friendsoftheroyallondonhospital.org.uk The Royal London Hospital

Powered by TCPDF (www.tcpdf.org)

You might also like